Startup profile · funding coverage
Ultima Genomics
Ultima Genomics builds ultra-low-cost, high-throughput DNA sequencing hardware targeting the $100 genome.
Stage
See coverage
Status
private
Coverage
full
Why Ultima Genomics is interesting
Sequencing cost curves unlock population-scale genomics; a16z joined a $600M stealth breakout alongside Khosla, Lightspeed, and Founders Fund.
Key facts
- Launch (May 2022): ~$600M from General Atlantic, a16z, D1, Khosla, Lightspeed, Founders Fund — Ultima blog, Bloomberg
- Claims $100 genome with novel high-throughput sequencing platform
Investors in our directory
Funds linked from Ultima Genomics's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Biotech & Life Sciences
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Ultima Genomics
Funding context and why this company shows up in venture coverage.
Ultima Genomics is listed among Andreessen Horowitz (a16z) investments on a16z’s public investment list.
We track a16z-backed companies that are strategically relevant for founders and investors following AI, American Dynamism, crypto, bio, and enterprise software.
Last updated: 2026-07-24